Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 11, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of specific share transactions rather than a financial performance report.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on May 10, 2007. Each individual acquired 9 shares through the personal contribution element and 9 shares through the matching element of the Company's ShareReward Plan. The purchase price was GBP 14.28 per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b) regarding director share transactions.
Key Facts for Investor Verification
- Transaction Date: May 10, 2007.
- Share Price: GBP 14.28 per Ordinary Share.
- Participants: Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty.
- Volume per Participant: 18 shares total (9 personal, 9 company match).
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.